MiMedx Group Receives FDA Warning Letter for Axiofill; Shares Decline 7%

MiMedx Group Receives FDA Warning Letter for Axiofill; Shares Decline 7%

MiMedx Group Inc, a biopharmaceutical company, reported on Friday that it has received a warning letter from the U.S. Food…